Trials / Completed
CompletedNCT01533688
Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients
Efficacy and Tolerability of Various Bowel Preparations in Diabetic Patients: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 212 (actual)
- Sponsor
- University of Oklahoma · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Poor bowel preparation and patient intolerance of the procedure are the most important factors contributing to the limitation of colonoscopy. Inadequate bowel cleansing results in incomplete testing, increased potential to miss lesions, increased cost, and decreased patient satisfaction. The investigators hope to gain better insight into which bowel preparation works best in diabetic patients and hence would increase patient satisfaction, tolerability of the bowel preparation and decrease overall costs. The investigators will investigate which bowel preparation for colonoscopy will work optimally in diabetic patients using three different regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Golytely (polyethylene glycol electrolyte lavage solution) and placebo | 4 liters of polyethylene glycol electrolyte lavage solution (PEG-ELS-(GoLytely))+ placebo given the evening prior to the colonoscopy |
| DRUG | split dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebo | split dose (2 L taken the evening before and 2 L taken the morning of the colonoscopy) of 4 liters Golytely + placebo |
| DRUG | split dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodyl | split dose ( 2 L taken the evening before and 2 L taken the morning of the colonoscopy) of 4 liters of Golytely + bisacodyl 10 mg |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2012-02-15
- Last updated
- 2018-09-07
- Results posted
- 2018-08-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01533688. Inclusion in this directory is not an endorsement.